Arovella Therapeutics (ASX:ALA) has announced that it has received firm commitments from institutional and sophisticated investors to raise approximately $15 million under a new placement. …
Arovella receives commitments for $15 million following cancellation of January placement
February 26, 2025 Australian Biotech
Latest Video
New Stories
-
Rare Cancers welcomes future funding for 'game-changing' cancer service
February 27, 2025 - - Latest News -
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 - - Latest News -
HTA go-slow on newborn screening leaves parents waiting and waiting
February 27, 2025 - - Latest News -
Officials blame companies for not highlighting quality of life benefits
February 26, 2025 - - Latest News -
US FDA accepts application for Telix's Zircaix and grants priority review
February 26, 2025 - - Australian Biotech -
Arovella receives commitments for $15 million following cancellation of January placement
February 26, 2025 - - Australian Biotech -
MTPConnect refreshes board with new appointment and retirement
February 26, 2025 -